Publications by authors named "Daniel Landsburg"

Claim this Profile
B
Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial.
Congying Xia, Amanda M Smith, Bénédicte Lefebvre, Faizi A Jamal, Saro H Armenian, Daniel Landsburg

JAMA Netw Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.
Taylor R Brooks, Emily C Zabor, Yohanna B Bedelu, Xi Yang, Yasmin H Karimi, Daniel J Landsburg

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.
Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis, Daniel Landsburg

J Natl Compr Canc Netw· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure.
Emily Anderson, Yun Choi, Rachel J Buchsbaum, Andreas Klein, Bonnie Ky, Daniel Landsburg

Leuk Lymphoma· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma.
Nikita K Dave, Veronica Carvajal, Alex C Watts, Jordan S Carter, Michael Cook, Daniel J Landsburg

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience.
Omar Elghawy, Julia Wang, Olivia J Leung, Nishwant Swami, Veronica Carvajal, Daniel J Landsburg

Clin Lymphoma Myeloma Leuk· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome.
Omar Elghawy, Jonathan H Sussman, Austin G Yang, Colin J Thomas, Jordan S Carter, Daniel J Landsburg

JAMA Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.
Jakub Svoboda, Daniel J Landsburg, James Gerson, Sunita D Nasta, Stefan K Barta

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Myc-Altered Pathology on Radiation Therapy Efficacy Among Patients With Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by ILROG.
Yolanda D Tseng, Phil Stevenson, Bachviet Nguyen, Davey C Li, Daniel Y Lee, Daniel Landsburg

Int J Radiat Oncol Biol Phys· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.
Vincent Ni, Sunita D Nasta, Stefan K Barta, Stephen J Schuster, Elise A Chong, Daniel J Landsburg

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell Therapy.
Luke Maillie, Sunita D Nasta, Jakub Svoboda, Stefan K Barta, Elise A Chong, Daniel J Landsburg

Transplant Cell Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers.
Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Daniel Landsburg

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome.
Omar Elghawy, Austin G Yang, Jonathan H Sussman, Colin J Thomas, Jordan S Carter, Daniel J Landsburg

J Am Acad Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry.
Daniel J Landsburg, Matthew J Frigault, Michael Heim, Stephen Ronan Foley, Brian Hill

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Histologic, Immunohistochemical and Genomic Features of Large B Cell Lymphoma Tumors May Predict Response to Polatuzumab Vedotin Based Therapy in Patients With Relapsed/Refractory Disease.
Michael Schneider, Sunita D Nasta, Stefan K Barta, Elise A Chong, Jakub Svoboda, Daniel J Landsburg

Clin Lymphoma Myeloma Leuk· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Cure Rates for Patients with Newly Diagnosed Large B-Cell Lymphomas: Targeted Therapies for High-Risk Pathologic Subgroups as Defined by Clinical Laboratory Testing.
Daniel J Landsburg

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Features of Newly Diagnosed Large B-cell Lymphoma with or without Subsequent Disease Progression.
Daniel J Landsburg, Jennifer J D Morrissette, Sunita D Nasta, Stefan K Barta, Stephen J Schuster

Cancer Res Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.
Narendranath Epperla, Adam S Zayac, Daniel J Landsburg, Allison M Bock, Grzegorz S Nowakowski

Blood Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas.
Omar Elghawy, Miao Cao, Jason Xu, Daniel J Landsburg, Jakub Svoboda

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma.
Elise A Chong, Emeline R Chong, Dylan Therwhanger, Sunita D Nasta, Daniel J Landsburg

Transplant Cell Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.
Rahul S Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Daniel J Landsburg

Blood Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia.
Elise A Chong, Kingsley Gideon Kumashie, Emeline R Chong, Joseph Fabrizio, Aditi Gupta, Daniel J Landsburg

J Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivianna M Van Deerlin, Jennifer J D Morrissette, Daniel J Landsburg

Nat Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel.
Guido Ghilardi, Luca Paruzzo, Vrutti Patel, Jakub Svoboda, Emeline R Chong, Daniel J Landsburg

J Hematol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-Cell Immunotherapy in Minority Patients with Lymphoma.
Guido Ghilardi, Staci Williamson, Raymone Pajarillo, Luca Paruzzo, Linhui Chen, Daniel J Landsburg

NEJM Evid· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis